Search Results
May 08, 2026, 02:18 ET Artprice News：リヨン・ビエンナーレ2026、国際的な現代美術の推進力を再定義
Philipsz、Laure Prouvost、raumlaborberlin、Miguel Rothschild、Selma Selman、Erwan Séné、Igor Šimić、Sriwhana Spong、Tina Stefanou、Mette Sterre、Michael Stevenson、Pol Taburet、Huda Takriti、Tsuneko Taniuchi、Ashleigh Taupaki、Minh Lan Tran、Thu-Van Tran、Álvaro Urbano、Kaylene Whiskey、Luke Willis Thompson、Candrani Yulis。展示会場
More news about: Artmarket.com
May 07, 2026, 19:07 ET Artprice News: Die Lyon-Biennale 2026 definiert die treibenden Kräfte der internationalen zeitgenössischen Kunst neu
Prouvost, raumlaborberlin, Miguel Rothschild, Selma Selman, Erwan Séné, Igor Šimić, Sriwhana Spong, Tina Stefanou, Mette Sterre, Michael Stevenson, Pol Taburet, Huda Takriti, Tsuneko Taniuchi, Ashleigh Taupaki, Minh Lan Tran, Thu-Van Tran, Álvaro Urbano, Kaylene Whiskey, Luke Willis Thompson, Candrani
More news about: Artmarket.com
May 07, 2026, 08:47 ET Noticias de Artprice: La Bienal de Lyon 2026 del arte contemporáneo internacional
Prouvost, raumlaborberlin, Miguel Rothschild, Selma Selman, Erwan Séné, Igor Šimić, Sriwhana Spong, Tina Stefanou, Mette Sterre, Michael Stevenson, Pol Taburet, Huda Takriti, Tsuneko Taniuchi, Ashleigh Taupaki, Minh Lan Tran, Thu-Van Tran, Álvaro Urbano, Kaylene Whiskey, Luke Willis Thompson, Candrani
More news about: Artmarket.com
May 06, 2026, 16:22 ET Artprice News: The Lyon Biennale 2026 redefines the driving forces of international contemporary art
Prouvost, raumlaborberlin, Miguel Rothschild, Selma Selman, Erwan Séné, Igor Šimić, Sriwhana Spong, Tina Stefanou, Mette Sterre, Michael Stevenson, Pol Taburet, Huda Takriti, Tsuneko Taniuchi, Ashleigh Taupaki, Minh Lan Tran, Thu-Van Tran, Álvaro Urbano, Kaylene Whiskey, Luke Willis Thompson, Candrani
More news about: Artmarket.com
May 06, 2026, 16:09 ET Artprice News: The Lyon Biennale 2026 redefines the driving forces of international contemporary art
Prouvost, raumlaborberlin, Miguel Rothschild, Selma Selman, Erwan Séné, Igor Šimić, Sriwhana Spong, Tina Stefanou, Mette Sterre, Michael Stevenson, Pol Taburet, Huda Takriti, Tsuneko Taniuchi, Ashleigh Taupaki, Minh Lan Tran, Thu-Van Tran, Álvaro Urbano, Kaylene Whiskey, Luke Willis Thompson, Candrani
More news about: Artmarket.com
May 06, 2026, 16:02 ET Artprice News : La Biennale de Lyon 2026 redéfinit les lignes de force de l'art contemporain international
Prouvost, raumlaborberlin, Miguel Rothschild, Selma Selman, Erwan Séné, Igor Šimić, Sriwhana Spong, Tina Stefanou, Mette Sterre, Michael Stevenson, Pol Taburet, Huda Takriti, Tsuneko Taniuchi, Ashleigh Taupaki, Minh Lan Tran, Thu-Van Tran, Álvaro Urbano, Kaylene Whiskey, Luke Willis Thompson, Candrani
More news about: Artmarket.com
May 05, 2026, 06:00 ET IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
2025, IDEAYA plans to discontinue development of IDE275, a small molecule inhibitor of Werner helicase (WRN), and IDE705, a small molecule inhibitor of Pol-Theta helicase (POLQ). The company is currently evaluating strategic options for these assets.CorporateIn
More news about: IDEAYA Biosciences, Inc.
May 04, 2026, 08:00 ET Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
expansion in the gastrointestinal tract DNA pol IIIC inhibitors demonstrate a class effect of potentially clinically-relevant gut microbiome preservation while demonstrating systemic antibacterial activityAcurx's DNA pol IIIC inhibitor preclinical product candidates are FDA
More news about: Acurx Pharmaceuticals, Inc.
May 01, 2026, 11:00 ET Dr. Pol Launches Non-Prescription Clinical Nutrition Dog Food Line Available Exclusively at Walmart
broader Dr. Pol family of pet food products, which also includes Incredi-Pol® Favorites and Incredi-Pol® Limited, featuring simplified, limited-ingredient recipes for everyday nutrition.ABOUT DR. POLWith more than 50 years in veterinary medicine, Dr. Jan Pol is widely
More news about: Consumers Supply Distributing
Apr 29, 2026, 08:00 ET Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 20, 2026, 08:00 ET Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 16, 2026, 16:01 ET Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 16, 2026, 08:00 ET Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Apr 01, 2026, 06:14 ET Built for Ultimate Touch Experience: Goodix Unveils Next‑Gen Flexible OLED Touch Controller GT9926
technology, effectively reducing interference to display signals and flicker issue. It is compatible with the latest flexible OLED technologies, including Pol‑less displays and Tandem OLED panels, enabling flagship‑level display performance without compromising touch responsiveness.Optimized Performance
More news about: Goodix
Mar 30, 2026, 07:01 ET Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
evidence that microbiome selectivity, when compared to the comparator antibiotic, linezolid, may be a class effect."He further stated: "Our lead DNA pol IIIC inhibitor, ibezapolstat, is ready to advance to international, Phase 3, pivotal registration trials in the US and EU for oral treatment of acute
More news about: Acurx Pharmaceuticals, Inc.
Mar 27, 2026, 11:32 ET Labor and Employment Firm Zakay Law Group APLC Files A Class Action Lawsuit Against Van De Pol Enterprises, Fuel Delivery Services and Silver State Petroleum Alleging Failure to Pay All Wages Due
Zakay Law Group, APLC, filed a class action complaint against Van De Pol Enterprises, Inc., Fuel Delivery Services, Inc. and Silver State Petroleum, Inc. (collectively, "Van De Pol Enterprises, Fuel Delivery Services and Silver State Petroleum") for allegedly failing
More news about: Zakay Law Group, APC
Mar 13, 2026, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
new colonic-microbiome data from a "state-of-the-art" mouse infection model showing a potential microbiome-sparing class effect of representative compounds from our DNA pol IIIC inhibitor preclinical pipeline.In November 2025, the Company announced that the Nature Communications Scientific Journal
More news about: Acurx Pharmaceuticals, Inc.
Mar 10, 2026, 10:37 ET ForwardX świętuje rok wdrożenia AMR na duża skalę w fabryce Chery w Dalian
robotów mobilnych i umożliwia skalowalne zarządzanie flotą oraz integrację z systemami WMS i MES klientów. Spółka ForwardX, mająca na swoim koncie ponad pół tysiąca wdrożeń na całym świecie, oferuje rozwiązania pomagające producentom i operatorom logistycznym zwiększać skalę niezawodnej automatyzacji w swoich
More news about: ForwardX Robotics
Mar 09, 2026, 08:01 ET Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Feb 19, 2026, 02:38 ET BPCL Accelerates Greenification of Natural Gas Ecosystem at GAIL Saksham Meet in Varanasi
and LPG distributors. Its distribution network comprises over 23,500+ Fuel Stations, over 6,200+ LPG distributorships, 500+ Lubes distributorships, 80 POL storage locations, 54 LPG Bottling Plants, 79 Aviation Service Stations, 5 Lube blending plants and 5 cross-country pipelines.Bharat Petroleum
More news about: Bharat Petroleum Corporation Limited (BPCL)
Feb 18, 2026, 03:52 ET BPCL Inaugurates 71 MWp Solar Power Plant at Prayagraj, Strengthening Its Renewable Energy Portfolio
and LPG distributors. Its distribution network comprises over 23,500+ Fuel Stations, over 6,200+ LPG distributorships, 500+ Lubes distributorships, 80 POL storage locations, 54 LPG Bottling Plants, 79 Aviation Service Stations, 5 Lube blending plants and 5 cross-country pipelines.Bharat Petroleum
More news about: Bharat Petroleum Corporation Limited (BPCL)
Feb 17, 2026, 06:00 ET IDEAYA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Collaboration, Option and License Agreement, dated June 15, 2020. Pursuant to the terms of the Agreement, GSK will transfer the Werner Helicase (IDE275) and Pol Theta (IDE705) clinical programs to IDEAYA in accordance with the applicable provisions of the Agreement.Fourth Quarter and Full Year
More news about: IDEAYA Biosciences, Inc.
Feb 16, 2026, 08:01 ET Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Feb 05, 2026, 06:40 ET TAT announces Amazing Thailand Chinese New Year 2026 in Bangkok and Hat Yai marking 51 years of Thailand-China relations
Khaoprasert, Deputy Governor of Suphan Buri Province; Acting Sub. Lt. Sarawoot Chantawong, Deputy Governor of Nakhon Sawan Province; and Pol. Maj. Gen. Kris Warit, Deputy Commissioner of the Tourist Police Bureau, reflecting strong institutional and regional cooperation in delivering the
More news about: Tourism Authority of Thailand
Feb 05, 2026, 06:40 ET TAT announces Amazing Thailand Chinese New Year 2026 in Bangkok and Hat Yai marking 51 years of Thailand-China relations
Khaoprasert, Deputy Governor of Suphan Buri Province; Acting Sub. Lt. Sarawoot Chantawong, Deputy Governor of Nakhon Sawan Province; and Pol. Maj. Gen. Kris Warit, Deputy Commissioner of the Tourist Police Bureau, reflecting strong institutional and regional cooperation in delivering the
More news about: Tourism Authority of Thailand